SCHEMBL24345234

SCHEMBL24345234

COc1ccc(C2=C/C(=C\c3ccccc3)C(=O)O2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.73
KMT2A Q03164 9/20 0.67
MEN1 O00255 8/20 0.67
ALDH1A1 P00352 6/20 0.67
SMN1; SMN2 Q16637 2/20 0.67
PKM P14618 2/20 0.67
L3MBTL1 Q9Y468 1/20 0.67
ALOX5 P09917 1/20 0.60
POLB P06746 3/20 0.58
XBP1 P17861 1/20 0.55
CRHBP P24387 1/20 0.52
CRHR2 Q13324 1/20 0.52
RECQL P46063 2/20 0.50
LMNA P02545 1/20 0.50
KDM4E B2RXH2 4/20 0.49
ALOX12 P18054 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
HSD17B10 Q99714 1/20 0.49
TDP1 Q9NUW8 2/20 0.48
SERPINE1 P05121 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1753097 0.94 MAPT (0.73) MAPTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL9300939 0.85 KMT2A (0.69) MAPTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL16080106 0.85 MAPT (0.62) MAPTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL197261 0.80 MAPT (0.75) MAPTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL12267450 0.80 MAPT (0.75) MAPTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL197262 0.80 MAPT (0.75) MAPTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL19721178 0.80 MAPT (0.68) MAPTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL10577536 0.79 MAPT (0.74) MAPTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL10577532 0.79 MAPT (0.74) MAPTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL20337574 0.76 MAPT (0.57) MAPTKMT2AMEN1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691135-B2 Synthesis of alkynones via carbonylative Sonogashira coupling reactions catalyzed by Pd(II)-N-Heterocyclic carbene-pyridine complexes KING FAHD UNIVERSITY OF PETROLEUM & MINERALS (SA) 2023-07-04 US disclosed
US-20220118435-A1 SYNTHESIS OF ALKYNONES VIA CARBONYLATIVE SONOGASHIRA COUPLING REACTIONS CATALYZED BY PD(II)-N-HETEROCYCLIC CARBENE-PYRIDINE COMPLEXES KING FAHD UNIVERSITY OF PETROLEUM & MINERALS (SA) 2022-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691135-B2 Synthesis of alkynones via carbonylative Sonogashira coupling reactions catalyzed by Pd(II)-N-Heterocyclic carbene-pyridine complexes PDK2, SNCA, YAP1 MAPT 3784/4885KMT2A 1519/4885MEN1 1330/4885
US-20220118435-A1 SYNTHESIS OF ALKYNONES VIA CARBONYLATIVE SONOGASHIRA COUPLING REACTIONS CATALYZED BY PD(II)-N-HETEROCYCLIC CARBENE-PYRIDINE COMPLEXES PDK2, SNCA, YAP1 MAPT 3784/4885KMT2A 1519/4885MEN1 1330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.